VRSA—doomsday superbug or damp squib?

The Lancet Infectious Diseases

Volume 10, Issue 12, December 2010, Pages 816-818

DI Hsu et al.
Comparison of method-specific vancomycin minimum inhibitory concentration values and their predictability for treatment outcome of meticillin-resistant Staphylococcus aureus (MRSA) infections
Int J Antimicrob. Agents
(2008)
R Herriman
Rare resistant staph infection seen in Pennsylvania hospital
DM Sievert et al.
Vancomycin-resistant Staphylococcus aureus in the United States, 2002–2006
Clin Infect Dis
(2008)
J Finks et al.
Vancomycin-resistant Staphylococcus aureus, Michigan, USA, 2007
Emerging Infect Dis
(2009)
B Saha et al.
Identification and characterization of a vancomycin-resistant Staphylococcus aureus isolated from Kolkata (South Asia)
J Med Microbiol
(2008)
M Aligholi et al.
Emergence of high-level vancomycin-resistant Staphylococcus aureus in the Imam Khomeini hospital in Tehran
Med Princ Pract
(2008)
ML Foucault et al.
Fitness cost of VanA-type vancomycin resistance in methicillin-resistant Staphylococcus aureus
Antimicrob Agents Chemother
(2009)

There are more references available in the full text version of this article.